1. Home
  2. SGLY vs BDRX Comparison

SGLY vs BDRX Comparison

Compare SGLY & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGLY
  • BDRX
  • Stock Information
  • Founded
  • SGLY 2001
  • BDRX 2000
  • Country
  • SGLY United States
  • BDRX United Kingdom
  • Employees
  • SGLY N/A
  • BDRX N/A
  • Industry
  • SGLY
  • BDRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SGLY
  • BDRX Health Care
  • Exchange
  • SGLY Nasdaq
  • BDRX Nasdaq
  • Market Cap
  • SGLY 4.5M
  • BDRX 3.8M
  • IPO Year
  • SGLY 2008
  • BDRX N/A
  • Fundamental
  • Price
  • SGLY $1.09
  • BDRX $5.32
  • Analyst Decision
  • SGLY
  • BDRX
  • Analyst Count
  • SGLY 0
  • BDRX 0
  • Target Price
  • SGLY N/A
  • BDRX N/A
  • AVG Volume (30 Days)
  • SGLY 44.5K
  • BDRX 45.5K
  • Earning Date
  • SGLY 09-26-2025
  • BDRX 09-29-2025
  • Dividend Yield
  • SGLY N/A
  • BDRX N/A
  • EPS Growth
  • SGLY N/A
  • BDRX N/A
  • EPS
  • SGLY N/A
  • BDRX N/A
  • Revenue
  • SGLY $2,172,036.00
  • BDRX N/A
  • Revenue This Year
  • SGLY N/A
  • BDRX N/A
  • Revenue Next Year
  • SGLY N/A
  • BDRX N/A
  • P/E Ratio
  • SGLY N/A
  • BDRX N/A
  • Revenue Growth
  • SGLY N/A
  • BDRX N/A
  • 52 Week Low
  • SGLY $0.54
  • BDRX $5.00
  • 52 Week High
  • SGLY $5.49
  • BDRX $112.85
  • Technical
  • Relative Strength Index (RSI)
  • SGLY 53.10
  • BDRX 30.67
  • Support Level
  • SGLY $0.94
  • BDRX $5.29
  • Resistance Level
  • SGLY $1.22
  • BDRX $5.96
  • Average True Range (ATR)
  • SGLY 0.10
  • BDRX 0.50
  • MACD
  • SGLY 0.00
  • BDRX 0.01
  • Stochastic Oscillator
  • SGLY 55.81
  • BDRX 14.54

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: